|
Economic analysis of a multicentre, randomised, phase III trial comparing FOLFOXIRI with FOLFIRI in patients with metastatic colorectal cancer in Greece |
Maniadakis N, Pallis A, Fragoulakis V, Prezerakos P, Georgoulias V |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Maniadakis N, Pallis A, Fragoulakis V, Prezerakos P, Georgoulias V. Economic analysis of a multicentre, randomised, phase III trial comparing FOLFOXIRI with FOLFIRI in patients with metastatic colorectal cancer in Greece. Current Medical Research and Opinion 2007; 23(9): 2251-2257 Indexing Status Subject indexing assigned by NLM MeSH Antineoplastic Combined Chemotherapy Protocols /economics /therapeutic use; Camptothecin /administration & Colorectal Neoplasms /drug therapy /economics /pathology; Cost of Illness; Fluorouracil /administration & Greece; Humans; Leucovorin /administration & Neoplasm Metastasis; Organoplatinum Compounds /administration & derivatives; dosage; dosage; dosage; dosage /analogs & AccessionNumber 22008000115 Date bibliographic record published 03/02/2009 |
|
|
|